Tarsons Products Limited IPO: GMP, Issue Price, Issue Size

Tarsons Products    
Rate this post

Tarsons Products Limited a leading Indian life sciences company with more than three decades of experience is all set to make a debut on the stock market with an issue size of 1023.47 Cr. The company manufactures a range of quality labware products that helps advance scientific discovery and improve healthcare systems.  

Tarsons Products IPO

Tarsons Products Limited IPO –Overview    

Tarsons Products Limited IPO Issue Date    15-17 November 2021   
Tarsons Products Limited IPO Opening Date    30 November 2021   
Tarsons Products Limited IPO Face Value    INR 2 per share    
Tarsons Products Limited IPO Price    INR 662 per share   
Tarsons Products Limited IPO Lot Size    22 Shares   
Issue Size    1,023.47   Cr   
Offer for sale    873.84   Cr   
Fresh Issue   150 cr   
Issue Type    Book built Issue IPO    
Listing At    BSE, NSE   
QIB Shares Offered      1.3 times   
NII (HNI) Shares    1.09 times   
Company Promoters    Sanjive Sehgal and Rohan Sehgal are the company promoters.  
Uniparts India IPO: 7 Important Points To Remember

Tarsons Products Limited IPO-Tentative Dates    

Tarsons Products Limited IPO opening date    15 November 2021     
Tarsons Products Limited IPO closing date    17 November 2021   
Basis of Allotment    23 November 2021   
Initiation of Refunds    24 November 2021   
Credit of Shares to Demat   25 November 2021   
Tarsons Products Limited IPO Listing Date    26 November 2021   

Tarsons Products – Industry Overview.   

The Indian pharmaceutical industry is the 3rd largest in the world by volume. However, despite this achievement, India is significantly dependent on the import of basic raw materials, viz., Bulk Drugs that are used to produce medicines. In some specific bulk drugs, the import dependence is 80 to 100%. The government plans to put in place a production-linked incentive (PLI) scheme to boost domestic manufacturing of critical key starting materials (KSMs) or drug intermediates, used to make bulk drugs, as well as APIs. The PLI could cost USD 911.5 Mn over the next eight years. Over 70% of India’s KSM and API import requirement is satisfied by China, mostly for antibiotics and vitamins.  

The Indian government recently concluded an assessment of India’s opportunity in global pharmaceutical R&D to evaluate the Department of Pharmaceuticals’ (Dop) vision of developing India as a drug discovery and pharmaceutical innovation hub.  

Tarsons Products Limited IPO – Company Overview    

Tarsons Products is a leading Indian life sciences company engaged in the designing, development, manufacturing and marketing of ‘consumables’, ‘reusables,’ and ‘others’ including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations (“CROs”), Diagnostic companies and hospitals. They manufacture a range of quality labware products that help advance scientific discovery and improve healthcare. As of March 31, 2021, they had a diversified product portfolio with over 1,700 SKUs across 300 products. The product portfolio is classified into three key categories which include consumables, reusables, and others. ‘Consumables’ category includes products such as centrifuge ware, cryogenic ware, liquid handling, PCR con consumables, petri dish, transfer pipettes, and others. ‘Reusables’ category includes products such as bottles, carboys, beakers, measuring cylinders, and tubes ‘Others’ category includes benchtop instrumentation such as vortex shakers, centrifuges pipettors, and others. 

Tarsons Products Limited IPO-Objectives    

  • Repayment/prepayment of all or certain of company’s borrowings.  
  • Funding a part of the capital expenditure for new manufacturing facility at Panchala, West Bengal.  
  • General corporate purposes.  

Tarsons Products Limited IPO – Financial Statements   

Particulars   30-Sep-21   31-Mar-21   
Total Assets   3,647.74  2,959.50  
Total Revenue   711.27  2,342.91  
Profit After Tax   248.35  688.70  

Tarsons Products Limited IPO Strengths   

  • Largest private health insurance company in India with leadership in the attractive retail health segment.   
  • It offers a Diverse range of labware products. 
  • Large addressable market with long-standing relationships.  
  • Well-equipped and automated manufacturing facilities. 

Tarsons Products Limited IPO Weakness    

  • Any delay, interruption, or reduction in the supply of raw materials to manufacture its products.  
  • Non-compliance with any changes in, safety, health, environment, and labor laws and other applicable regulations.  

Company Contact Information

Tarsons Products Limited
Martin Burn Buisness Park,
Room No. 902 BP- 3, Salt Lake,
Sector- V, Kolkata 700091
Phone: +91 33 3522 0
Email: piyush@tarsons.in

Tarsons Products IPO Registrar

KFin Technologies Limited

Phone: 04067162222, 04079611000
Email: tarsonsproducts.ipo@kfintech.com

Tarsons Products IPO Lead Manager(s)

  1. Edelweiss Financial Services Ltd 
  2. ICICI Securities Limited 
  3. SBI Capital Markets Limited


Please enter your comment!
Please enter your name here